Central Effects of Endogenous GLP-1 and the GLP-1 Analog Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
Phase of Trial: Phase IV
Latest Information Update: 01 Apr 2016
At a glance
- Drugs Liraglutide (Primary) ; Glucagon-like peptide-1; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms LIBRA
- 10 Jun 2017 Biomarkers information updated
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 May 2012 Actual initiation date (Oct 2011) added as reported by ClinicalTrials.gov.